J. Silva

Sorting hidden patterns in nanoparticle performance for glioblastoma using machine learning algorithms.

R. Eritja, Tânia Cova, A. Pais, 2020, International journal of pharmaceutics.

Cell Membrane-Mimetic Nanoparticles for Cancer Treatment: What Has Been Done So Far?

J. Sousa, A. Pais, Maria Mendes, 2020 .

Biomimeting ultra-small lipid nanoconstructs forglioblastoma treatment: a computationally guided experimental approach.

Tânia Cova, A. Pais, Maria Mendes, 2020, International journal of pharmaceutics.

Tailoring drug and gene codelivery nanosystems for glioblastoma treatment

J. Sousa, A. Pais, Maria Mendes, 2021 .

Development and full validation of an HPLC methodology to quantify atorvastatin and curcumin after their intranasal co-delivery to mice.

A. Fortuna, C. Vitorino, J. Basso, 2019, Biomedical chromatography : BMC.

Impact of Immunotherapy in the Treatment of Glioblastoma

A. Pais, C. Vitorino, Ana Miranda, 2018, Biopharmaceuticals.

Cell Cycle Markers in the Evaluation of Bladder Cancer

A. Ranzi, T. Graziottin, C. Bica, 2018, Pathology & Oncology Research.

Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment.

M. Castelo‐Branco, Tânia Cova, A. Pais, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles

J. Sousa, Tânia Cova, A. Pais, 2018, AAPS PharmSciTech.

Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles

J. Sousa, Tânia Cova, A. Pais, 2018, AAPS PharmSciTech.

Cell Cycle Markers in the Evaluation of Bladder Cancer

A. Ranzi, T. Graziottin, C. Bica, 2018, Pathology & Oncology Research.